Liquid Biopsy: Physicians, Patients, Beware!
Liquid biopsy may detect cancer recurrence, changes in the tumor, and development of drug resistance -- eventually, says Dr. George Lundberg. But for now, patients and physicians should be wary. (Source: Medscape Oncology)
Source: Medscape Oncology - March 19, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Oophorectomy Prevents Ovarian Cancer
Dr. Maurie Markman suggests that the findings of this study be shared with women with the BRCA+ mutation. (Source: Medscape Oncology)
Source: Medscape Oncology - March 14, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
No Bull's Eye Without a Target
Dr. Mark Kris stresses that EGFR-targeted therapies provide no benefit in lung cancer patients who have no activating mutations, as evidenced in a recent study. (Source: Medscape Oncology)
Source: Medscape Oncology - March 10, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Caution! Anti-EGFR Therapy May Endanger mCRC Patients
Dr. John Marshall reports that in patients with metastatic colorectal cancer, anti-EGFR therapy could not only prove ineffective but actually harmful, depending on their RAS mutations. (Source: Medscape Oncology)
Source: Medscape Oncology - February 24, 2014 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
